Adam Snook, PhD, received a BS in Pharmacology and Toxicology (2001) from the University of the Sciences and a PhD in Immunology and Microbial Pathogenesis (2008) from Thomas Jefferson University.

He joined the faculty at Thomas Jefferson University in 2013 in the Department of Pharmacology and Experimental Therapeutics where he is studying the mechanisms underlying colorectal cancer tumorigenesis and the interaction between cancer and the immune system to develop new options to prevent or treat gastrointestinal cancers. His work has led to seven investigator-initiated clinical trials examining colorectal cancer chemoprevention, cancer vaccines, and CAR-T cell therapies.

Dr. Snook has authored over 80 book chapters and papers in prestigious journals, including Cancer Research, Gastroenterology, Journal of Clinical Investigation, Journal for Immunotherapy of Cancer (JITC), Cancer Immunology Research, and Cancer Cell, and his work has been featured in Nature Outlook, US News and World Report, Forbes, Reuters, The Washington Post, The New York Times, The Philadelphia Inquirer, and others.